Global Pandemic Treaty Talks Extend Amid Deep Divisions in Geneva

It’s 7:30 a.m. On a Monday in downtown Austin, and the line at Jo’s Coffee on Congress Avenue is already snaking past the historic Paramount Theatre. Among the early risers—tech workers, city council aides, and a few nurses from Dell Seton Medical Center—there’s a quiet but persistent hum of conversation about the news breaking out of Geneva. Another week of high-stakes negotiations has just kicked off to finalize the missing piece of the world’s first pandemic treaty, and for a city that still bears the scars of COVID-19’s economic and emotional toll, the outcome isn’t just global policy—it’s personal.

For Austinites, this isn’t abstract diplomacy. It’s about whether the next pandemic will leave local hospitals scrambling for ventilators like they did in 2020, or whether the city’s biotech sector—home to companies like Luminex and Asuragen—will finally have a clear framework for sharing life-saving research without getting tangled in red tape. The treaty’s most contentious sticking point, the Pathogen Access and Benefit-Sharing (PABS) system, could determine whether Austin’s labs get early access to emerging virus samples or whether they’ll be left waiting while wealthier nations hoard data. And with the U.S. Notably absent from the final adoption last year, the stakes feel even higher for cities like Austin, which have built their post-pandemic recovery on the promise of resilience.

The Missing Piece: Why PABS Is the Linchpin

The World Health Organization’s Pandemic Agreement, adopted in May 2025, was hailed as a historic step toward global health equity. But its success hinges on the yet-to-be-finalized PABS system, an annex designed to ensure that countries share pathogen samples and genetic sequencing data in real time during outbreaks—while also guaranteeing that the benefits of that research, like vaccines and treatments, are distributed fairly. Think of it as a global “fair trade” agreement for viruses: if a lab in Austin sequences a fresh flu strain, the system is supposed to ensure that the data isn’t locked behind paywalls or national borders, and that any resulting medical breakthroughs don’t just end up in the hands of the highest bidder.

The problem? Negotiations have hit a wall. Wealthy nations, including the U.S., have pushed back against binding commitments to share 20% of pandemic-related medical products with the WHO for distribution to lower-income countries. Meanwhile, developing nations argue that without enforceable guarantees, the treaty is just a piece of paper. The current impasse in Geneva isn’t just about percentages—it’s about power. And for a city like Austin, where the University of Texas’s Dell Medical School and the Texas Advanced Computing Center (TACC) play pivotal roles in global health research, the outcome could reshape everything from grant funding to local job markets.

What’s at Stake for Austin: A City on the Front Lines

Austin’s relationship with pandemics isn’t just theoretical. During COVID-19, the city’s tech-driven response—like the ATX Health Commons, a collaboration between local startups and public health officials—became a model for rapid data sharing and community outreach. But it also exposed vulnerabilities. When the Delta variant surged in 2021, Austin Public Health had to ration monoclonal antibody treatments, and local clinics in underserved neighborhoods like Dove Springs and Rundberg struggled to keep up with demand. The treaty’s PABS system could prevent those inequities from repeating, but only if it’s structured to prioritize speed and transparency over corporate or national interests.

For Austin’s biotech sector, the treaty’s success could mean more federal funding and international partnerships. Companies like Ginkgo Bioworks, which has a growing presence in the city, rely on global data sharing to develop diagnostics and therapeutics. If PABS falters, those pipelines could dry up, leaving local startups at a disadvantage. “We’re not just talking about abstract policy here,” says a researcher at UT Austin’s Center for Pandemic Decision Science (who asked not to be named due to ongoing negotiations). “If the treaty fails to create a fair system, it’s Austin’s labs—and Austin’s patients—that will pay the price.”

There’s also the economic angle. Austin’s reputation as a hub for innovation has attracted billions in venture capital, much of it flowing into health tech. A strong PABS system could bolster that growth by ensuring local companies aren’t cut out of global supply chains. But if the treaty collapses or is watered down, the city could see investment shift to more predictable markets—like Boston or San Francisco—where the rules of engagement are clearer.

The U.S. Absence: A Shadow Over Local Preparedness

The elephant in the room is the U.S.’s decision not to ratify the Pandemic Agreement last year. While the Biden administration supported the treaty in principle, opposition in Congress—fueled by concerns over sovereignty and intellectual property—blocked ratification. The absence of the world’s largest economy has left cities like Austin in a bind. Without U.S. Participation, the treaty’s enforcement mechanisms are weaker, and American companies and research institutions may opt out of the PABS system entirely. That could leave Austin’s labs and hospitals operating in a legal gray area, where sharing data with international partners becomes a liability rather than an asset.

For local public health officials, the U.S. Absence is a major headache. “We’re trying to build a regional pandemic response plan, but it’s hard to do that when the federal government isn’t at the table,” says Dr. Mark Escott, the former interim health authority for Austin-Travis County, who now advises the city on emergency preparedness. “If the treaty’s PABS system doesn’t get finalized, we’re back to square one—relying on ad-hoc agreements and goodwill, which we saw fail spectacularly during COVID.”

The Local Ripple Effects: From Hospitals to Startups

So what does all this mean for Austinites? The treaty’s fate could touch nearly every corner of the city:

• Hospitals: Ascension Seton and St. David’s HealthCare, which serve as regional hubs for critical care, could face delays in accessing new treatments if the PABS system isn’t robust. During COVID, Austin’s hospitals had to navigate a patchwork of state and federal guidelines to secure remdesivir and other drugs. A strong treaty could streamline that process.
• Startups: Austin’s health tech scene, which includes companies like Everly Health and Wheel, could see slower growth if the treaty fails to create a predictable framework for global collaboration. Investors may hesitate to fund ventures that rely on international data sharing if the rules are unclear.
• Public Health: Austin Public Health, which has been working to rebuild trust in communities of color after COVID’s disproportionate impact, could struggle to deliver equitable care if the treaty doesn’t prioritize vaccine and treatment access for underserved populations.
• Education: UT Austin’s School of Public Health, which trains the next generation of epidemiologists and health policy experts, could see its global partnerships shrink if the treaty doesn’t create a stable environment for international research.

What Happens Next: A Week That Could Change Everything

The negotiations in Geneva are expected to wrap up by May 1, with the Intergovernmental Working Group (IGWG) racing to finalize the PABS annex. If they succeed, the full Pandemic Agreement could enter into force as early as this summer, once 60 countries ratify it. But if the talks collapse, the world—and Austin—could be left without a coordinated plan for the next pandemic.

For a city that’s still recovering from the last one, that’s a terrifying prospect. “We can’t afford to be reactive again,” says Escott. “Austin has the talent, the infrastructure, and the community spirit to lead on pandemic preparedness. But we need a global system that supports us—not one that leaves us fighting for scraps.”

Given My Background in Global Health Policy, Here’s Who Consider Talk to in Austin

If you’re in Austin and this treaty’s outcome could impact your work, your health, or your business, here are the three types of local professionals you’ll want to connect with—along with exactly what to look for when hiring them:

1. Global Health Law Specialists

These are the attorneys who understand the intersection of international treaties, U.S. Law, and local compliance. Look for:

• Experience with the WHO’s International Health Regulations (IHR) or past global health agreements.
• Background in intellectual property law, especially as it relates to pharmaceuticals and biotech.
• Connections to Austin’s biotech sector—many of these lawyers work closely with local startups and research institutions.
• Fluency in the PABS system’s legal implications, including how it might interact with Texas state laws.

Why they matter: If the treaty’s PABS system is finalized, these lawyers will help Austin’s companies and hospitals navigate the new rules—ensuring they can share data and access treatments without running afoul of U.S. Or international law.

2. Public Health Supply Chain Consultants

During COVID, Austin’s hospitals and clinics struggled with supply chain disruptions—from PPE shortages to delays in diagnostic tests. These consultants specialize in building resilient local and global supply chains for medical products. Look for:

• Experience working with the Texas Department of State Health Services (DSHS) or local hospital systems like Ascension Seton.
• Knowledge of the treaty’s proposed global logistics network and how it might integrate with Austin’s existing infrastructure.
• Background in emergency preparedness, particularly in coordinating between state, federal, and international suppliers.
• Connections to Austin’s manufacturing sector—some local companies, like Flex, have pivoted to producing medical supplies and could play a role in future pandemics.

Why they matter: If the treaty’s PABS system succeeds, these consultants will help Austin’s hospitals and clinics tap into a more reliable global supply chain. If it fails, they’ll be critical in building local alternatives.

3. Community Health Equity Advocates

The treaty’s emphasis on equity is one of its most promising—and contentious—features. These advocates work to ensure that Austin’s most vulnerable communities aren’t left behind in the next pandemic. Look for:

• Deep ties to Austin’s underserved neighborhoods, particularly in East Austin, Dove Springs, and Rundberg.
• Experience with the city’s COVID-19 response, including vaccine distribution and testing site placement.
• Knowledge of the treaty’s equity provisions and how they might be implemented at the local level.
• Partnerships with organizations like Austin Voices for Education and Youth or the Dell Medical School’s Health Equity Policy Lab.

Why they matter: If the treaty’s PABS system prioritizes equitable access to treatments, these advocates will be on the front lines, ensuring that Austin’s response doesn’t repeat the mistakes of COVID-19. If the treaty fails, they’ll be the ones pushing for local solutions.

Ready to discover trusted professionals? Browse our complete directory of top-rated world experts in the Austin area today.